NaPro BioTherapeutics Establishes Genomics Division; University of Delaware s Kmiec Directs | GenomeWeb

NEW YORK, Sept. 18 — NaPro BioTherapeutics of Boulder, Col., said it recently established a genomics division, NaPro Genomics, under the scientific direction of Eric Kmiec at the University of Delaware’s Delaware Biotechnology Institute. Kmiec, who invented and developed a targeted gene repair technology that NaPro licensed, directs g enomics research at the institute and is an associate professor in the university’s department of biological sciences.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.